All Announcements
FRONTEO identifies 450 candidate compounds in research on COVID-19
FRONTEO announces the identification of 450 candidate compounds in its research on the novel coronavirus through their proprietary AI system “Cascade Eye”.
Read MoreFRONTEO constructs pathway map of coronavirus infection to be published for use in Therapeutic Drug Selection and Review
FRONTEO announces the successful creation of a pathway map for the novel coronavirus infection (COVID-19), using its proprietary AI system “Cascade Eye”.
Read MoreFRONTEO Managed Review Service moves to remote-work using VDI solutions
FRONTEO migrates its Managed Review Service serviced in the United States to work from home (WFH) remote solution based on Google Cloud due to the recent outbreak of COVID-19, in order to protect their employees and continue to serve their clients.
Read MoreFRONTEO USA, Inc. Announces Change to U.S. Leadership
FRONTEO has appointed Yutaka Okura as CEO of FRONTEO USA effective August 1st.
Read MoreFRONTEO Opens Managed Review Center in Florida
FRONTEO USA, Inc. announced the opening of its new review center in Ft. Lauderdale, Florida.
Read More